Sergei Timofeevski

4.6k citations

17 papers · 606 indexed · h-index 14

Co-authors: Steven D. Aust Michael D. Cameron N. Scott Reading Michele McTigue Brion W. Murray Helen Y. Zou James G. Christensen Ping Chen
Topics: PI3K/AKT/mTOR signaling in cancer (4 papers)Enzyme-mediated dye degradation (3 papers)Melanoma and MAPK Pathways (3 papers)
Cited by: Biotechnology Hepatology Pollution
Journals: Journal of Biological Chemistry PLoS ONE Biochemistry
Partner nations: United States Switzerland China

In The Last Decade

Sergei Timofeevski

17 papers receiving 587 citations

Peers

Countries citing papers authored by Sergei Timofeevski

Since Specialization

Citations

This map shows the geographic impact of Sergei Timofeevski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergei Timofeevski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergei Timofeevski more than expected).

Fields of papers citing papers by Sergei Timofeevski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergei Timofeevski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergei Timofeevski. The network helps show where Sergei Timofeevski may publish in the future.

Co-authorship network of co-authors of Sergei Timofeevski

This figure shows the co-authorship network connecting the top 25 collaborators of Sergei Timofeevski. A scholar is included among the top collaborators of Sergei Timofeevski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergei Timofeevski. Sergei Timofeevski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Multiple conformational states of the HPK1 kinase domain in complex with sunitinib reveal the structural changes accompanying HPK1 trans-regulation 2019 ·Journal of Biological Chemistry ·Eric F. Johnson,Michele McTigue,Rebecca A. Gallego,Ted W. Johnson,Sergei Timofeevski,(unknown),Timothy S. Fisher,Robert S. Kania,Sansana Sawasdikosol,Steven J. Burakoff,Ciarán N. Cronin	21
2	Reviving B-Factors: Activating ALK Mutations Increase Protein Dynamics of the Unphosphorylated Kinase 2018 ·ACS Medicinal Chemistry Letters ·Ted W. Johnson,Ben Bolaños,Alexei Brooun,Rebecca A. Gallego,(unknown),Mehran Jalaie,Michele McTigue,Sergei Timofeevski	6
3	The Axl kinase domain in complex with a macrocyclic inhibitor offers first structural insights into an active TAM receptor kinase 2017 ·Journal of Biological Chemistry ·K.S. Gajiwala,Neil B. Grodsky,Ben Bolaños,Junli Feng,Rose Ann Ferre,Sergei Timofeevski,Meirong Xu,Brion W. Murray,Ted W. Johnson,Al Stewart	41
4	Mitotic Checkpoint Kinase Mps1 Has a Role in Normal Physiology which Impacts Clinical Utility 2015 ·PLoS ONE ·Ricardo Martínez,Alessandra Blasina,Jill Hallin,Wenyue Hu,(unknown),(unknown),Robert L. Hoffman,Sean T. Murphy,Matthew A. Marx,Gina M. Yanochko,(unknown),Dac M. Dinh,Sergei Timofeevski,Zhou Zhu,(unknown),Patrick B. Lappin,Brion W. Murray	29
5	Engineering of an isolated p110α subunit of PI3Kα permits crystallization and provides a platform for structure‐based drug design 2014 ·Protein Science ·Ping Chen,Ya‐Li Deng,Simon Bergqvist,Matthew D. Falk,Wei Liu,Sergei Timofeevski,Alexei Brooun	22
6	Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors 2014 ·Bioscience Reports ·Matthew D. Falk,Wei Liu,Ben Bolaños,Keziban Ünsal-Kaçmaz,Anke Klippel,Stephan K. Grant,Alexei Brooun,Sergei Timofeevski	18
7	Abstract A277: PF-06463922, a novel ROS1/ALK inhibitor, demonstrates sub-nanomolar potency against oncogenic ROS1 fusions and capable of blocking the resistant ROS1G2032R mutant in preclinical tumor models. 2013 ·Molecular Cancer Therapeutics ·Helen Y. Zou,(unknown),Qiuhua Li,(unknown),(unknown),Hui Wang,Konstantinos Tsaparikos,Sergei Timofeevski,Justine L. Lam,Shinji Yamazaki,Wenyue Hu,Hovhannes J. Gukasyan,Nathan Lee,Ted W. Johnson,Valeria R. Fantin,Tod Smeal	9
8	Sensitivity of Selected Human Tumor Models to PF-04217903, a Novel Selective c-Met Kinase Inhibitor 2012 ·Molecular Cancer Therapeutics ·Helen Y. Zou,Qiuhua Li,Joseph H. Lee,Maria E. Arango,(unknown),Ming Qiu,Lars D. Engstrom,Shinji Yamazaki,(unknown),Sergei Timofeevski,Jingrong Jean Cui,Michele McTigue,Gerrit Los,Steven L. Bender,Tod Smeal,James G. Christensen	57
9	Abstract 2327: Structural and kinetic characterization of crizotinib with wild-type and mutant anaplastic lymphoma kinase 2011 ·Cancer Research ·Michele McTigue,Sergei Timofeevski,Wei Liu,Ya‐Li Deng,Tami Marrone,Jean Cui,Alexei Brooun	1
10	Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·Paul S. Humphries,Jennifer Lafontaine,(unknown),David Alexánder,Ping Chen,(unknown),Lilian Y. Li,Elizabeth A. Lunney,(unknown),Karen Lohmann Siegel,Sergei Timofeevski,Tianlun Wang,(unknown)	18
11	Enzymatic Characterization of c-Met Receptor Tyrosine Kinase Oncogenic Mutants and Kinetic Studies with Aminopyridine and Triazolopyrazine Inhibitors 2009 ·Biochemistry ·Sergei Timofeevski,Michele McTigue,Kevin Ryan,Jean Cui,Helen Y. Zou,Jeff Zhu,(unknown),Gordon Alton,(unknown),James G. Christensen,Brion W. Murray	75
12	Identification of small-molecule inhibitors of the JIP–JNK interaction 2009 ·Biochemical Journal ·Tracy Chen,Natasha M. Kablaoui,(unknown),Sergei Timofeevski,William R. Tschantz,Ping Chen,Junli Feng,Maura E. Charlton,Robert V. Stanton,Paul H. Bauer	47
13	Pharmacological characterization of a small molecule inhibitor of c-Jun kinase 2008 ·American Journal of Physiology-Endocrinology and Metabolism ·(unknown),Shawn C. Black,(unknown),(unknown),Dawn Kelly-Sullivan,Sergei Timofeevski,Karen Lohmann Siegel,(unknown),Scott R. McDonnell,Ping Chen,Junming Yie,Kathleen M. Ogilvie,James D. Fraser,Celia P. Briscoe	22
14	Isoform-Selective Interaction of Cyclooxygenase-2 with Indomethacin Amides Studied by Real-Time Fluorescence, Inhibition Kinetics, and Site-Directed Mutagenesis 2002 ·Biochemistry ·Sergei Timofeevski,Jeffery J. Prusakiewicz,Carol A. Rouzer,Lawrence J. Marnett	17
15	Enzymology of Phanerochaete chrysosporium with respect to the degradation of recalcitrant compounds and xenobiotics 2000 ·Applied Microbiology and Biotechnology ·Michael D. Cameron,Sergei Timofeevski,Steven D. Aust	162
16	Substrate Specificity of Lignin Peroxidase and a S168W Variant of Manganese Peroxidase 2000 ·Archives of Biochemistry and Biophysics ·Sergei Timofeevski,(unknown),N. Scott Reading,Steven D. Aust	28
17	Addition of Veratryl Alcohol Oxidase Activity to Manganese Peroxidase by Site-Directed Mutagenesis 1999 ·Biochemical and Biophysical Research Communications ·Sergei Timofeevski,(unknown),N. Scott Reading,Steven D. Aust	33

About Sergei Timofeevski

Sergei Timofeevski is a scholar working on Hepatology, Oncology and Analytical Chemistry, having authored 17 papers that have together received 606 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Enzyme-mediated dye degradation (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Biotechnology (102 citations), Hepatology (71 citations) and Pollution (69 citations). Sergei Timofeevski has collaborated with scholars based in United States, Switzerland and China. Frequent co-authors include Steven D. Aust, Michael D. Cameron, N. Scott Reading, Michele McTigue, Brion W. Murray, Helen Y. Zou, James G. Christensen, Ping Chen, Junli Feng and Ted W. Johnson. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact